Correlation Between BioNTech and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both BioNTech and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Apogee Therapeutics, Common, you can compare the effects of market volatilities on BioNTech and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Apogee Therapeutics,.
Diversification Opportunities for BioNTech and Apogee Therapeutics,
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between BioNTech and Apogee is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of BioNTech i.e., BioNTech and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between BioNTech and Apogee Therapeutics,
Given the investment horizon of 90 days BioNTech SE is expected to generate 0.95 times more return on investment than Apogee Therapeutics,. However, BioNTech SE is 1.05 times less risky than Apogee Therapeutics,. It trades about 0.09 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.23 per unit of risk. If you would invest 11,394 in BioNTech SE on August 31, 2024 and sell it today you would earn a total of 678.00 from holding BioNTech SE or generate 5.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioNTech SE vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| BioNTech SE |
| Apogee Therapeutics, |
BioNTech and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioNTech and Apogee Therapeutics,
The main advantage of trading using opposite BioNTech and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| BioNTech vs. Cue Biopharma | BioNTech vs. Tff Pharmaceuticals | BioNTech vs. Eliem Therapeutics | BioNTech vs. Inhibrx |
| Apogee Therapeutics, vs. Cue Biopharma | Apogee Therapeutics, vs. Tff Pharmaceuticals | Apogee Therapeutics, vs. Eliem Therapeutics | Apogee Therapeutics, vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |